PaperPanda Equity Terminal

KRYS logo KRYS — Krystal Biotech

CUSIP: 501147102 · Held by 4 superinvestors · Combined value: $107,300,841

Latest News

Loading financials…

Quarterly Activity Chart Adds vs. Reduces by Quarter
Green bars = share additions · Red bars = share reductions
Superinvestor Holders
# Investor % of Portfolio Value ($) Shares Recent Activity Share Change
1 Ken Griffin 0.0% $100,910,055 409,305 REDUCE -271,883
2 Torray LLC 0.5% $3,108,106 12,032 ADD +47
3 Ray Dalio 0.0% $2,469,098 10,015 ADD +292
4 Jim Simons 0.0% $813,582 3,300 NEW BUY +3,300
Quarterly Activity History (3 quarters)
Investor Activity Share Change % Change
Torray LLC ADD +47 +0.4%
Investor Activity Share Change % Change
Jim Simons NEW BUY +3,300 New
Ray Dalio ADD +292 +3.0%
Torray LLC ADD +84 +0.7%
Ken Griffin REDUCE -271,883 -39.9%
Investor Activity Share Change % Change
Ray Dalio NEW BUY +9,723 New
Ken Griffin ADD +606,628 +813.6%
Jim Simons SOLD -89,800 Exit

Who Owns KRYS? Superinvestor Holdings

Krystal Biotech is held by 4 tracked superinvestors, with a combined position value of $107 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Torray LLC (0.5% of portfolio), Ray Dalio (0.0% of portfolio).

In the most recent quarter, 3 superinvestors added or initiated positions while 1 reduced or exited.